The purpose of this work was to test the diagnostic value of dobutamine str
ess magnetic resonance imaging (MRI) for predicting recovery of regional my
ocardial contractility after revascularization. Cardiac wall motion abnorma
lities are due to either non-viable and/or scarred, or viable, but hibernat
ing, myocardial tissue. Dobutamine stress leads to increased systolic wall
thickening only in viable myocardium. Twenty-five patients with akinetic or
dyskinetic myocardial regions were examined with a Cine FLASH-2D sequence
at rest and during dobutamine stress (10 mu g/kg/min). Patients were re-exa
mined at rest 3, and ist case of persisting wall motion defects, 6 months a
fter revascularization. Criterion of viability was increasing end-systolic
wall thickening during stress and/or at follow-up. Akinetic regions related
either to the LAD (n = 19) or to the RCA (n = 6) were judged viable if >=5
0% of the affected segments improved. MR studies were completed in all subj
ects without arrhythmia or need for early terminations due to symptoms. Sen
sitivity, specificity, and positive predictive value for the prediction of
myocardial viability were 61%, 90%, and 87% for the segment-related analysi
s, and 76%, 100%, and 100% for the patient-related analysis based on corona
ry artery distribution, respectively. Dobutamiue stress MRI allows to predi
ct global functional recovery of akinetic myocardial regions after revascul
arization with a high positive predictive value and high specificity. (C) 1
999 Elsevier Science Inc.